Global Patent Drug Market Research Report 2024, Forecast to 2032
Report Overview
A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
The global Patent Drug market size was estimated at USD 1071000 million in 2023 and is projected to reach USD 1661472.52 million by 2032, exhibiting a CAGR of 5.00% during the forecast period.
North America Patent Drug market size was estimated at USD 303505.04 million in 2023, at a CAGR of 4.29% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Patent Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Patent Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Patent Drug market in any manner.
Global Patent Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Market Segmentation (by Type)
Oral
Injection
Other
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Patent Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Patent Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
The global Patent Drug market size was estimated at USD 1071000 million in 2023 and is projected to reach USD 1661472.52 million by 2032, exhibiting a CAGR of 5.00% during the forecast period.
North America Patent Drug market size was estimated at USD 303505.04 million in 2023, at a CAGR of 4.29% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Patent Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Patent Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Patent Drug market in any manner.
Global Patent Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Market Segmentation (by Type)
Oral
Injection
Other
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Patent Drug Market
- Overview of the regional outlook of the Patent Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Patent Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Patent Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Patent Drug
1.2 Key Market Segments
1.2.1 Patent Drug Segment by Type
1.2.2 Patent Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PATENT DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Patent Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Patent Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PATENT DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Patent Drug Sales by Manufacturers (2019-2024)
3.2 Global Patent Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Patent Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Patent Drug Sales Sites, Area Served, Product Type
3.6 Patent Drug Market Competitive Situation and Trends
3.6.1 Patent Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Patent Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PATENT DRUG INDUSTRY CHAIN ANALYSIS
4.1 Patent Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PATENT DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PATENT DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Patent Drug Sales Market Share by Type (2019-2024)
6.3 Global Patent Drug Market Size Market Share by Type (2019-2024)
6.4 Global Patent Drug Price by Type (2019-2024)
7 PATENT DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Patent Drug Market Sales by Application (2019-2024)
7.3 Global Patent Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Patent Drug Sales Growth Rate by Application (2019-2024)
8 PATENT DRUG MARKET CONSUMPTION BY REGION
8.1 Global Patent Drug Sales by Region
8.1.1 Global Patent Drug Sales by Region
8.1.2 Global Patent Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Patent Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Patent Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Patent Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Patent Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Patent Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 PATENT DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Patent Drug by Region (2019-2024)
9.2 Global Patent Drug Revenue Market Share by Region (2019-2024)
9.3 Global Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Patent Drug Production
9.4.1 North America Patent Drug Production Growth Rate (2019-2024)
9.4.2 North America Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Patent Drug Production
9.5.1 Europe Patent Drug Production Growth Rate (2019-2024)
9.5.2 Europe Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Patent Drug Production (2019-2024)
9.6.1 Japan Patent Drug Production Growth Rate (2019-2024)
9.6.2 Japan Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Patent Drug Production (2019-2024)
9.7.1 China Patent Drug Production Growth Rate (2019-2024)
9.7.2 China Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Patent Drug Basic Information
10.1.2 Pfizer Patent Drug Product Overview
10.1.3 Pfizer Patent Drug Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Patent Drug SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Roche
10.2.1 Roche Patent Drug Basic Information
10.2.2 Roche Patent Drug Product Overview
10.2.3 Roche Patent Drug Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche Patent Drug SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Sanofi
10.3.1 Sanofi Patent Drug Basic Information
10.3.2 Sanofi Patent Drug Product Overview
10.3.3 Sanofi Patent Drug Product Market Performance
10.3.4 Sanofi Patent Drug SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Patent Drug Basic Information
10.4.2 Johnson and Johnson Patent Drug Product Overview
10.4.3 Johnson and Johnson Patent Drug Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Merck and Co. (MSD)
10.5.1 Merck and Co. (MSD) Patent Drug Basic Information
10.5.2 Merck and Co. (MSD) Patent Drug Product Overview
10.5.3 Merck and Co. (MSD) Patent Drug Product Market Performance
10.5.4 Merck and Co. (MSD) Business Overview
10.5.5 Merck and Co. (MSD) Recent Developments
10.6 Novartis
10.6.1 Novartis Patent Drug Basic Information
10.6.2 Novartis Patent Drug Product Overview
10.6.3 Novartis Patent Drug Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 AbbVie
10.7.1 AbbVie Patent Drug Basic Information
10.7.2 AbbVie Patent Drug Product Overview
10.7.3 AbbVie Patent Drug Product Market Performance
10.7.4 AbbVie Business Overview
10.7.5 AbbVie Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Patent Drug Basic Information
10.8.2 Gilead Sciences Patent Drug Product Overview
10.8.3 Gilead Sciences Patent Drug Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Patent Drug Basic Information
10.9.2 GlaxoSmithKline (GSK) Patent Drug Product Overview
10.9.3 GlaxoSmithKline (GSK) Patent Drug Product Market Performance
10.9.4 GlaxoSmithKline (GSK) Business Overview
10.9.5 GlaxoSmithKline (GSK) Recent Developments
10.10 Amgen
10.10.1 Amgen Patent Drug Basic Information
10.10.2 Amgen Patent Drug Product Overview
10.10.3 Amgen Patent Drug Product Market Performance
10.10.4 Amgen Business Overview
10.10.5 Amgen Recent Developments
10.11 AstraZeneca
10.11.1 AstraZeneca Patent Drug Basic Information
10.11.2 AstraZeneca Patent Drug Product Overview
10.11.3 AstraZeneca Patent Drug Product Market Performance
10.11.4 AstraZeneca Business Overview
10.11.5 AstraZeneca Recent Developments
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Patent Drug Basic Information
10.12.2 Bristol-Myers Squibb Patent Drug Product Overview
10.12.3 Bristol-Myers Squibb Patent Drug Product Market Performance
10.12.4 Bristol-Myers Squibb Business Overview
10.12.5 Bristol-Myers Squibb Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Patent Drug Basic Information
10.13.2 Eli Lilly Patent Drug Product Overview
10.13.3 Eli Lilly Patent Drug Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Teva
10.14.1 Teva Patent Drug Basic Information
10.14.2 Teva Patent Drug Product Overview
10.14.3 Teva Patent Drug Product Market Performance
10.14.4 Teva Business Overview
10.14.5 Teva Recent Developments
10.15 Bayer
10.15.1 Bayer Patent Drug Basic Information
10.15.2 Bayer Patent Drug Product Overview
10.15.3 Bayer Patent Drug Product Market Performance
10.15.4 Bayer Business Overview
10.15.5 Bayer Recent Developments
10.16 Novo Nordisk
10.16.1 Novo Nordisk Patent Drug Basic Information
10.16.2 Novo Nordisk Patent Drug Product Overview
10.16.3 Novo Nordisk Patent Drug Product Market Performance
10.16.4 Novo Nordisk Business Overview
10.16.5 Novo Nordisk Recent Developments
10.17 AbbVie
10.17.1 AbbVie Patent Drug Basic Information
10.17.2 AbbVie Patent Drug Product Overview
10.17.3 AbbVie Patent Drug Product Market Performance
10.17.4 AbbVie Business Overview
10.17.5 AbbVie Recent Developments
10.18 Takeda
10.18.1 Takeda Patent Drug Basic Information
10.18.2 Takeda Patent Drug Product Overview
10.18.3 Takeda Patent Drug Product Market Performance
10.18.4 Takeda Business Overview
10.18.5 Takeda Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Patent Drug Basic Information
10.19.2 Boehringer Ingelheim Patent Drug Product Overview
10.19.3 Boehringer Ingelheim Patent Drug Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Takeda
10.20.1 Takeda Patent Drug Basic Information
10.20.2 Takeda Patent Drug Product Overview
10.20.3 Takeda Patent Drug Product Market Performance
10.20.4 Takeda Business Overview
10.20.5 Takeda Recent Developments
11 PATENT DRUG MARKET FORECAST BY REGION
11.1 Global Patent Drug Market Size Forecast
11.2 Global Patent Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Patent Drug Market Size Forecast by Country
11.2.3 Asia Pacific Patent Drug Market Size Forecast by Region
11.2.4 South America Patent Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Patent Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Patent Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Patent Drug by Type (2025-2032)
12.1.2 Global Patent Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Patent Drug by Type (2025-2032)
12.2 Global Patent Drug Market Forecast by Application (2025-2032)
12.2.1 Global Patent Drug Sales (K MT) Forecast by Application
12.2.2 Global Patent Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Patent Drug
1.2 Key Market Segments
1.2.1 Patent Drug Segment by Type
1.2.2 Patent Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PATENT DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Patent Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Patent Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PATENT DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Patent Drug Sales by Manufacturers (2019-2024)
3.2 Global Patent Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Patent Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Patent Drug Sales Sites, Area Served, Product Type
3.6 Patent Drug Market Competitive Situation and Trends
3.6.1 Patent Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Patent Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PATENT DRUG INDUSTRY CHAIN ANALYSIS
4.1 Patent Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PATENT DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PATENT DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Patent Drug Sales Market Share by Type (2019-2024)
6.3 Global Patent Drug Market Size Market Share by Type (2019-2024)
6.4 Global Patent Drug Price by Type (2019-2024)
7 PATENT DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Patent Drug Market Sales by Application (2019-2024)
7.3 Global Patent Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Patent Drug Sales Growth Rate by Application (2019-2024)
8 PATENT DRUG MARKET CONSUMPTION BY REGION
8.1 Global Patent Drug Sales by Region
8.1.1 Global Patent Drug Sales by Region
8.1.2 Global Patent Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Patent Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Patent Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Patent Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Patent Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Patent Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 PATENT DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Patent Drug by Region (2019-2024)
9.2 Global Patent Drug Revenue Market Share by Region (2019-2024)
9.3 Global Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Patent Drug Production
9.4.1 North America Patent Drug Production Growth Rate (2019-2024)
9.4.2 North America Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Patent Drug Production
9.5.1 Europe Patent Drug Production Growth Rate (2019-2024)
9.5.2 Europe Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Patent Drug Production (2019-2024)
9.6.1 Japan Patent Drug Production Growth Rate (2019-2024)
9.6.2 Japan Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Patent Drug Production (2019-2024)
9.7.1 China Patent Drug Production Growth Rate (2019-2024)
9.7.2 China Patent Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Patent Drug Basic Information
10.1.2 Pfizer Patent Drug Product Overview
10.1.3 Pfizer Patent Drug Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Patent Drug SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Roche
10.2.1 Roche Patent Drug Basic Information
10.2.2 Roche Patent Drug Product Overview
10.2.3 Roche Patent Drug Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche Patent Drug SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Sanofi
10.3.1 Sanofi Patent Drug Basic Information
10.3.2 Sanofi Patent Drug Product Overview
10.3.3 Sanofi Patent Drug Product Market Performance
10.3.4 Sanofi Patent Drug SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Patent Drug Basic Information
10.4.2 Johnson and Johnson Patent Drug Product Overview
10.4.3 Johnson and Johnson Patent Drug Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Merck and Co. (MSD)
10.5.1 Merck and Co. (MSD) Patent Drug Basic Information
10.5.2 Merck and Co. (MSD) Patent Drug Product Overview
10.5.3 Merck and Co. (MSD) Patent Drug Product Market Performance
10.5.4 Merck and Co. (MSD) Business Overview
10.5.5 Merck and Co. (MSD) Recent Developments
10.6 Novartis
10.6.1 Novartis Patent Drug Basic Information
10.6.2 Novartis Patent Drug Product Overview
10.6.3 Novartis Patent Drug Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 AbbVie
10.7.1 AbbVie Patent Drug Basic Information
10.7.2 AbbVie Patent Drug Product Overview
10.7.3 AbbVie Patent Drug Product Market Performance
10.7.4 AbbVie Business Overview
10.7.5 AbbVie Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Patent Drug Basic Information
10.8.2 Gilead Sciences Patent Drug Product Overview
10.8.3 Gilead Sciences Patent Drug Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Patent Drug Basic Information
10.9.2 GlaxoSmithKline (GSK) Patent Drug Product Overview
10.9.3 GlaxoSmithKline (GSK) Patent Drug Product Market Performance
10.9.4 GlaxoSmithKline (GSK) Business Overview
10.9.5 GlaxoSmithKline (GSK) Recent Developments
10.10 Amgen
10.10.1 Amgen Patent Drug Basic Information
10.10.2 Amgen Patent Drug Product Overview
10.10.3 Amgen Patent Drug Product Market Performance
10.10.4 Amgen Business Overview
10.10.5 Amgen Recent Developments
10.11 AstraZeneca
10.11.1 AstraZeneca Patent Drug Basic Information
10.11.2 AstraZeneca Patent Drug Product Overview
10.11.3 AstraZeneca Patent Drug Product Market Performance
10.11.4 AstraZeneca Business Overview
10.11.5 AstraZeneca Recent Developments
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Patent Drug Basic Information
10.12.2 Bristol-Myers Squibb Patent Drug Product Overview
10.12.3 Bristol-Myers Squibb Patent Drug Product Market Performance
10.12.4 Bristol-Myers Squibb Business Overview
10.12.5 Bristol-Myers Squibb Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Patent Drug Basic Information
10.13.2 Eli Lilly Patent Drug Product Overview
10.13.3 Eli Lilly Patent Drug Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Teva
10.14.1 Teva Patent Drug Basic Information
10.14.2 Teva Patent Drug Product Overview
10.14.3 Teva Patent Drug Product Market Performance
10.14.4 Teva Business Overview
10.14.5 Teva Recent Developments
10.15 Bayer
10.15.1 Bayer Patent Drug Basic Information
10.15.2 Bayer Patent Drug Product Overview
10.15.3 Bayer Patent Drug Product Market Performance
10.15.4 Bayer Business Overview
10.15.5 Bayer Recent Developments
10.16 Novo Nordisk
10.16.1 Novo Nordisk Patent Drug Basic Information
10.16.2 Novo Nordisk Patent Drug Product Overview
10.16.3 Novo Nordisk Patent Drug Product Market Performance
10.16.4 Novo Nordisk Business Overview
10.16.5 Novo Nordisk Recent Developments
10.17 AbbVie
10.17.1 AbbVie Patent Drug Basic Information
10.17.2 AbbVie Patent Drug Product Overview
10.17.3 AbbVie Patent Drug Product Market Performance
10.17.4 AbbVie Business Overview
10.17.5 AbbVie Recent Developments
10.18 Takeda
10.18.1 Takeda Patent Drug Basic Information
10.18.2 Takeda Patent Drug Product Overview
10.18.3 Takeda Patent Drug Product Market Performance
10.18.4 Takeda Business Overview
10.18.5 Takeda Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Patent Drug Basic Information
10.19.2 Boehringer Ingelheim Patent Drug Product Overview
10.19.3 Boehringer Ingelheim Patent Drug Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Takeda
10.20.1 Takeda Patent Drug Basic Information
10.20.2 Takeda Patent Drug Product Overview
10.20.3 Takeda Patent Drug Product Market Performance
10.20.4 Takeda Business Overview
10.20.5 Takeda Recent Developments
11 PATENT DRUG MARKET FORECAST BY REGION
11.1 Global Patent Drug Market Size Forecast
11.2 Global Patent Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Patent Drug Market Size Forecast by Country
11.2.3 Asia Pacific Patent Drug Market Size Forecast by Region
11.2.4 South America Patent Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Patent Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Patent Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Patent Drug by Type (2025-2032)
12.1.2 Global Patent Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Patent Drug by Type (2025-2032)
12.2 Global Patent Drug Market Forecast by Application (2025-2032)
12.2.1 Global Patent Drug Sales (K MT) Forecast by Application
12.2.2 Global Patent Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Patent Drug Market Size Comparison by Region (M USD)
Table 5. Global Patent Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Patent Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Patent Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Patent Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Table 10. Global Market Patent Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Patent Drug Sales Sites and Area Served
Table 12. Manufacturers Patent Drug Product Type
Table 13. Global Patent Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Patent Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Patent Drug Market Challenges
Table 22. Global Patent Drug Sales by Type (K MT)
Table 23. Global Patent Drug Market Size by Type (M USD)
Table 24. Global Patent Drug Sales (K MT) by Type (2019-2024)
Table 25. Global Patent Drug Sales Market Share by Type (2019-2024)
Table 26. Global Patent Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Patent Drug Market Size Share by Type (2019-2024)
Table 28. Global Patent Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global Patent Drug Sales (K MT) by Application
Table 30. Global Patent Drug Market Size by Application
Table 31. Global Patent Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global Patent Drug Sales Market Share by Application (2019-2024)
Table 33. Global Patent Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Patent Drug Market Share by Application (2019-2024)
Table 35. Global Patent Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Patent Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global Patent Drug Sales Market Share by Region (2019-2024)
Table 38. North America Patent Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe Patent Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Patent Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America Patent Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Patent Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global Patent Drug Production (K MT) by Region (2019-2024)
Table 44. Global Patent Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Patent Drug Revenue Market Share by Region (2019-2024)
Table 46. Global Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Pfizer Patent Drug Basic Information
Table 52. Pfizer Patent Drug Product Overview
Table 53. Pfizer Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Pfizer Business Overview
Table 55. Pfizer Patent Drug SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Roche Patent Drug Basic Information
Table 58. Roche Patent Drug Product Overview
Table 59. Roche Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Roche Business Overview
Table 61. Roche Patent Drug SWOT Analysis
Table 62. Roche Recent Developments
Table 63. Sanofi Patent Drug Basic Information
Table 64. Sanofi Patent Drug Product Overview
Table 65. Sanofi Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Sanofi Patent Drug SWOT Analysis
Table 67. Sanofi Business Overview
Table 68. Sanofi Recent Developments
Table 69. Johnson and Johnson Patent Drug Basic Information
Table 70. Johnson and Johnson Patent Drug Product Overview
Table 71. Johnson and Johnson Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Johnson and Johnson Business Overview
Table 73. Johnson and Johnson Recent Developments
Table 74. Merck and Co. (MSD) Patent Drug Basic Information
Table 75. Merck and Co. (MSD) Patent Drug Product Overview
Table 76. Merck and Co. (MSD) Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Merck and Co. (MSD) Business Overview
Table 78. Merck and Co. (MSD) Recent Developments
Table 79. Novartis Patent Drug Basic Information
Table 80. Novartis Patent Drug Product Overview
Table 81. Novartis Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. AbbVie Patent Drug Basic Information
Table 85. AbbVie Patent Drug Product Overview
Table 86. AbbVie Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. AbbVie Business Overview
Table 88. AbbVie Recent Developments
Table 89. Gilead Sciences Patent Drug Basic Information
Table 90. Gilead Sciences Patent Drug Product Overview
Table 91. Gilead Sciences Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Recent Developments
Table 94. GlaxoSmithKline (GSK) Patent Drug Basic Information
Table 95. GlaxoSmithKline (GSK) Patent Drug Product Overview
Table 96. GlaxoSmithKline (GSK) Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. GlaxoSmithKline (GSK) Business Overview
Table 98. GlaxoSmithKline (GSK) Recent Developments
Table 99. Amgen Patent Drug Basic Information
Table 100. Amgen Patent Drug Product Overview
Table 101. Amgen Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Amgen Business Overview
Table 103. Amgen Recent Developments
Table 104. AstraZeneca Patent Drug Basic Information
Table 105. AstraZeneca Patent Drug Product Overview
Table 106. AstraZeneca Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Recent Developments
Table 109. Bristol-Myers Squibb Patent Drug Basic Information
Table 110. Bristol-Myers Squibb Patent Drug Product Overview
Table 111. Bristol-Myers Squibb Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Recent Developments
Table 114. Eli Lilly Patent Drug Basic Information
Table 115. Eli Lilly Patent Drug Product Overview
Table 116. Eli Lilly Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Recent Developments
Table 119. Teva Patent Drug Basic Information
Table 120. Teva Patent Drug Product Overview
Table 121. Teva Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Teva Business Overview
Table 123. Teva Recent Developments
Table 124. Bayer Patent Drug Basic Information
Table 125. Bayer Patent Drug Product Overview
Table 126. Bayer Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Bayer Business Overview
Table 128. Bayer Recent Developments
Table 129. Novo Nordisk Patent Drug Basic Information
Table 130. Novo Nordisk Patent Drug Product Overview
Table 131. Novo Nordisk Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Novo Nordisk Business Overview
Table 133. Novo Nordisk Recent Developments
Table 134. AbbVie Patent Drug Basic Information
Table 135. AbbVie Patent Drug Product Overview
Table 136. AbbVie Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. AbbVie Business Overview
Table 138. AbbVie Recent Developments
Table 139. Takeda Patent Drug Basic Information
Table 140. Takeda Patent Drug Product Overview
Table 141. Takeda Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Takeda Business Overview
Table 143. Takeda Recent Developments
Table 144. Boehringer Ingelheim Patent Drug Basic Information
Table 145. Boehringer Ingelheim Patent Drug Product Overview
Table 146. Boehringer Ingelheim Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Boehringer Ingelheim Business Overview
Table 148. Boehringer Ingelheim Recent Developments
Table 149. Takeda Patent Drug Basic Information
Table 150. Takeda Patent Drug Product Overview
Table 151. Takeda Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Takeda Business Overview
Table 153. Takeda Recent Developments
Table 154. Global Patent Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Patent Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Patent Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Patent Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Patent Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Patent Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Patent Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Patent Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Patent Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Patent Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Patent Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Patent Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Patent Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Patent Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Patent Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Patent Drug Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Patent Drug Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Patent Drug Market Size Comparison by Region (M USD)
Table 5. Global Patent Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Patent Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Patent Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Patent Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Table 10. Global Market Patent Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Patent Drug Sales Sites and Area Served
Table 12. Manufacturers Patent Drug Product Type
Table 13. Global Patent Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Patent Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Patent Drug Market Challenges
Table 22. Global Patent Drug Sales by Type (K MT)
Table 23. Global Patent Drug Market Size by Type (M USD)
Table 24. Global Patent Drug Sales (K MT) by Type (2019-2024)
Table 25. Global Patent Drug Sales Market Share by Type (2019-2024)
Table 26. Global Patent Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Patent Drug Market Size Share by Type (2019-2024)
Table 28. Global Patent Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global Patent Drug Sales (K MT) by Application
Table 30. Global Patent Drug Market Size by Application
Table 31. Global Patent Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global Patent Drug Sales Market Share by Application (2019-2024)
Table 33. Global Patent Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Patent Drug Market Share by Application (2019-2024)
Table 35. Global Patent Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Patent Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global Patent Drug Sales Market Share by Region (2019-2024)
Table 38. North America Patent Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe Patent Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Patent Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America Patent Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Patent Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global Patent Drug Production (K MT) by Region (2019-2024)
Table 44. Global Patent Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Patent Drug Revenue Market Share by Region (2019-2024)
Table 46. Global Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Patent Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Pfizer Patent Drug Basic Information
Table 52. Pfizer Patent Drug Product Overview
Table 53. Pfizer Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Pfizer Business Overview
Table 55. Pfizer Patent Drug SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Roche Patent Drug Basic Information
Table 58. Roche Patent Drug Product Overview
Table 59. Roche Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Roche Business Overview
Table 61. Roche Patent Drug SWOT Analysis
Table 62. Roche Recent Developments
Table 63. Sanofi Patent Drug Basic Information
Table 64. Sanofi Patent Drug Product Overview
Table 65. Sanofi Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Sanofi Patent Drug SWOT Analysis
Table 67. Sanofi Business Overview
Table 68. Sanofi Recent Developments
Table 69. Johnson and Johnson Patent Drug Basic Information
Table 70. Johnson and Johnson Patent Drug Product Overview
Table 71. Johnson and Johnson Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Johnson and Johnson Business Overview
Table 73. Johnson and Johnson Recent Developments
Table 74. Merck and Co. (MSD) Patent Drug Basic Information
Table 75. Merck and Co. (MSD) Patent Drug Product Overview
Table 76. Merck and Co. (MSD) Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Merck and Co. (MSD) Business Overview
Table 78. Merck and Co. (MSD) Recent Developments
Table 79. Novartis Patent Drug Basic Information
Table 80. Novartis Patent Drug Product Overview
Table 81. Novartis Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. AbbVie Patent Drug Basic Information
Table 85. AbbVie Patent Drug Product Overview
Table 86. AbbVie Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. AbbVie Business Overview
Table 88. AbbVie Recent Developments
Table 89. Gilead Sciences Patent Drug Basic Information
Table 90. Gilead Sciences Patent Drug Product Overview
Table 91. Gilead Sciences Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Recent Developments
Table 94. GlaxoSmithKline (GSK) Patent Drug Basic Information
Table 95. GlaxoSmithKline (GSK) Patent Drug Product Overview
Table 96. GlaxoSmithKline (GSK) Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. GlaxoSmithKline (GSK) Business Overview
Table 98. GlaxoSmithKline (GSK) Recent Developments
Table 99. Amgen Patent Drug Basic Information
Table 100. Amgen Patent Drug Product Overview
Table 101. Amgen Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Amgen Business Overview
Table 103. Amgen Recent Developments
Table 104. AstraZeneca Patent Drug Basic Information
Table 105. AstraZeneca Patent Drug Product Overview
Table 106. AstraZeneca Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Recent Developments
Table 109. Bristol-Myers Squibb Patent Drug Basic Information
Table 110. Bristol-Myers Squibb Patent Drug Product Overview
Table 111. Bristol-Myers Squibb Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Recent Developments
Table 114. Eli Lilly Patent Drug Basic Information
Table 115. Eli Lilly Patent Drug Product Overview
Table 116. Eli Lilly Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Recent Developments
Table 119. Teva Patent Drug Basic Information
Table 120. Teva Patent Drug Product Overview
Table 121. Teva Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Teva Business Overview
Table 123. Teva Recent Developments
Table 124. Bayer Patent Drug Basic Information
Table 125. Bayer Patent Drug Product Overview
Table 126. Bayer Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Bayer Business Overview
Table 128. Bayer Recent Developments
Table 129. Novo Nordisk Patent Drug Basic Information
Table 130. Novo Nordisk Patent Drug Product Overview
Table 131. Novo Nordisk Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Novo Nordisk Business Overview
Table 133. Novo Nordisk Recent Developments
Table 134. AbbVie Patent Drug Basic Information
Table 135. AbbVie Patent Drug Product Overview
Table 136. AbbVie Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. AbbVie Business Overview
Table 138. AbbVie Recent Developments
Table 139. Takeda Patent Drug Basic Information
Table 140. Takeda Patent Drug Product Overview
Table 141. Takeda Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Takeda Business Overview
Table 143. Takeda Recent Developments
Table 144. Boehringer Ingelheim Patent Drug Basic Information
Table 145. Boehringer Ingelheim Patent Drug Product Overview
Table 146. Boehringer Ingelheim Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Boehringer Ingelheim Business Overview
Table 148. Boehringer Ingelheim Recent Developments
Table 149. Takeda Patent Drug Basic Information
Table 150. Takeda Patent Drug Product Overview
Table 151. Takeda Patent Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Takeda Business Overview
Table 153. Takeda Recent Developments
Table 154. Global Patent Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Patent Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Patent Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Patent Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Patent Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Patent Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Patent Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Patent Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Patent Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Patent Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Patent Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Patent Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Patent Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Patent Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Patent Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Patent Drug Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Patent Drug Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Patent Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Patent Drug Market Size (M USD), 2019-2032
Figure 5. Global Patent Drug Market Size (M USD) (2019-2032)
Figure 6. Global Patent Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Patent Drug Market Size by Country (M USD)
Figure 11. Patent Drug Sales Share by Manufacturers in 2023
Figure 12. Global Patent Drug Revenue Share by Manufacturers in 2023
Figure 13. Patent Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Patent Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Patent Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Patent Drug Market Share by Type
Figure 18. Sales Market Share of Patent Drug by Type (2019-2024)
Figure 19. Sales Market Share of Patent Drug by Type in 2023
Figure 20. Market Size Share of Patent Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Patent Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Patent Drug Market Share by Application
Figure 24. Global Patent Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Patent Drug Sales Market Share by Application in 2023
Figure 26. Global Patent Drug Market Share by Application (2019-2024)
Figure 27. Global Patent Drug Market Share by Application in 2023
Figure 28. Global Patent Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Patent Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Patent Drug Sales Market Share by Country in 2023
Figure 32. U.S. Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Patent Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Patent Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Patent Drug Sales Market Share by Country in 2023
Figure 37. Germany Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Patent Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Patent Drug Sales Market Share by Region in 2023
Figure 44. China Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Patent Drug Sales and Growth Rate (K MT)
Figure 50. South America Patent Drug Sales Market Share by Country in 2023
Figure 51. Brazil Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Patent Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Patent Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Patent Drug Production Market Share by Region (2019-2024)
Figure 62. North America Patent Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Patent Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Patent Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China Patent Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Patent Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Patent Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Patent Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Patent Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Patent Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Patent Drug Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Patent Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Patent Drug Market Size (M USD), 2019-2032
Figure 5. Global Patent Drug Market Size (M USD) (2019-2032)
Figure 6. Global Patent Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Patent Drug Market Size by Country (M USD)
Figure 11. Patent Drug Sales Share by Manufacturers in 2023
Figure 12. Global Patent Drug Revenue Share by Manufacturers in 2023
Figure 13. Patent Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Patent Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Patent Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Patent Drug Market Share by Type
Figure 18. Sales Market Share of Patent Drug by Type (2019-2024)
Figure 19. Sales Market Share of Patent Drug by Type in 2023
Figure 20. Market Size Share of Patent Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Patent Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Patent Drug Market Share by Application
Figure 24. Global Patent Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Patent Drug Sales Market Share by Application in 2023
Figure 26. Global Patent Drug Market Share by Application (2019-2024)
Figure 27. Global Patent Drug Market Share by Application in 2023
Figure 28. Global Patent Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Patent Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Patent Drug Sales Market Share by Country in 2023
Figure 32. U.S. Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Patent Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Patent Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Patent Drug Sales Market Share by Country in 2023
Figure 37. Germany Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Patent Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Patent Drug Sales Market Share by Region in 2023
Figure 44. China Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Patent Drug Sales and Growth Rate (K MT)
Figure 50. South America Patent Drug Sales Market Share by Country in 2023
Figure 51. Brazil Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Patent Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Patent Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Patent Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Patent Drug Production Market Share by Region (2019-2024)
Figure 62. North America Patent Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Patent Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Patent Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China Patent Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Patent Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Patent Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Patent Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Patent Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Patent Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Patent Drug Market Share Forecast by Application (2025-2032)
